Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones With Laser
Condition(s) studied
Investigational drug(s) / intervention(s)
Furosemide 40 mg: Injection of 40 mg of Furosemide during 10 minutes after the end of the flexible ureteroscopy for destruction of kidney stones with laser.
Study summary
In view of the positive results of the numerous studies conducted on forced diuresis after extra-corporeal lithotripsy, the investigators chose to evaluate forced diuresis by injection of Furosemide associated with intravenous hydration, which has never before been the subject of a specific analysis.
Eligibility
Primary outcome measure(s)
- Rate of stone free patients — At 3 months
Rate of stone-free patients 3 months after a flexible ureteroscopy for renal stone laser destruction, evaluated on the low dose abdomino-pelvic CT-Scan. A centralized review of the images will be performed by two specialized radiologists, in a blind and crossed way to allow a homogenization of the results
Trial sites (9)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU d'Angers | Angers | France | Recruiting |
| Hospices Civils de Lyon | Lyon | France | Recruiting |
| CHU de Nice | Nice | France | Recruiting |
| CHU de Nîmes | Nîmes | France | Recruiting |
| CHU de Rennes | Rennes | France | Recruiting |
| CHU de Rouen | Rouen | France | Recruiting |
| CHU de Toulouse | Toulouse | France | Recruiting |
| Clinique La Croix du Sud | Toulouse | France | Recruiting |
| CHRU de Tours | Tours | France | Recruiting |
More University Hospital, Tours trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05916963 on ClinicalTrials.gov ↗ ← All trials in France